Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "avp research"

Citigroup Inc. Lowers Avon Products Price Target to $10.00

Avon Products (NYSE:AVP) had its price objective trimmed by Citigroup Inc. from $11.00 to $10.00 in a research report released on Wednesday morning. Citigroup Inc. currently has a neutral rating on the stock. Shares of Avon Products (NYSE:AVP) ... Ticker Report, 6 hours ago

6 images for avp research

Mideast Time, 3 weeks ago
American Banking News, 1 month ago
Manila Bulletin, 2 months ago
Manila Bulletin, 2 months ago
Mideast Time, 2 months ago
American Banking News, 2 months ago

Hindalco Q2 earnings: A mixed bag, say experts

In an interview to CNBC-TV18, Tarang Bhanushali, AVP- Research of IIFL along with Giriraj Daga, Senior Research Analyst at Nirmal Bang Institutional Equities spoke about the financial performance of the company in the quarter gone by and the road ...
 Moneycontrol.com1 month ago Here's how experts read Wipro's Q2FY15 earnings  Money Control1 month ago

Accumulate Bajaj Auto, says Prayesh Jain

According to Prayesh Jain, AVP - Research at IIFL, one may accumulate Bajaj Auto.
 Money Control2 months ago Prefer Hero Motocorp over Bajaj Auto: Prayesh Jain  Money Control2 months ago

Avon Products Now Covered by Analysts at Piper Jaffray (AVP)

Equities research analysts at Piper Jaffray initiated coverage on shares of Avon Products (NYSE:AVP) A number of other analysts have also recently weighed in on AVP. Analysts at Citigroup Inc. cut their price target on shares of Avon Products from ...
 American Banking News9 hours ago Piper Jaffray Begins Coverage on Avon Products (AVP)  Ticker Report1 day ago Avon Products Now Covered by Piper Jaffray (AVP)  SleekMoney1 day ago Avon Products Rating Reiterated by Zacks (AVP)  SleekMoney3 weeks ago

Healthcare Policy Analyst or AVP - Rapidly Growing/ Well Respected Research Firm | Confidential

Rapidly growing healthcare-focused research and advisory boutique catering to institutional investors, with offices in NY and DC, is looking to expand by hiring for two DC-based positions: an Analyst or Associate level and an Assistant Vice ...
 Associations Now Magazine2 weeks ago
Mideast Time

Research Analysts Ratings Reiterations for November, 27th (ABM, AVGO, AVP, BECN, DE, EMG, EPD, HOG, HPQ, IBM)

Research Analysts ratings reiterations for Thursday, November 27th: ABM Industries (NYSE:ABM) had its neutral rating reiterated by analysts at Zacks. They currently have a $29.00 target price on the stock. Zacks analyst wrote, ABM's third-quarter ...
 Mideast Time3 weeks ago

Startups mine global institutes for research talent

MUMBAI: Talent analytics startup Jombay is on the prowl for research talent and CEO Mohit Gundecha has set his sights on no less than Stanford University and USC, Berkeley. Gundecha reached out to his alma mater Stanford through the alumni network ...
 Economic Times3 weeks ago

A Brief Recap of Avon's Performance in 2014

Avon Products (NYSE:AVP), the direct selling company of beauty, household and personal care products, experienced a rough year in 2014. The company seems to be on a downhill trend, having posted its last profit back in 2011. Avon's direct selling ...
 Trefis1 day ago Avon announces management restructure to support turnaround plan  Individual.com4 weeks ago Avon Products Downgraded to $11: Delayed Turnaround and Tepid Business Outlook Weigh on Valuation  Trefis1 month ago

Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA

ALISO VIEJO, Calif. -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for AVP-825. AVP-825 is an investigational ...
 FierceBiotech2 weeks ago Avanir Pharmaceuticals : Receives Complete Response Letter CRL from FDA on AVP-825 NDA  4 Traders2 weeks ago AVANIR Pharmaceuticals (AVNR) Receives Complete Response Letter (CRL) From FDA On AVP-825 NDA 12/1/2014  ClinicSpace2 weeks ago Avanir's AVP-825 Approval Could be Delayed (Revised)  Yahoo! Finance1 month ago

Teva Presents Positive Safety and Efficacy Data for QNASLĀ®; Avanir Announces Preliminary Feedback from the FDA on AVP-825

[November 07, 2014] (BioMed Reports Via Acquire Media NewsEdge) Below is a look at some of the headlines for companies that made news in the healthcare sector on November 7, 2014.{nfg}Teva Pharmaceutical Industries Ltd., ...
 TMC Net1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less